Increased Signal in the Subarachnoid Space on Fluid-Attenuated Inversion Recovery Imaging Associated with the Clearance Dynamics of Gadolinium Chelate: A Potential Diagnostic Pitfall

References

1. ↵
   Adams JG, Melhem ER. Clinical usefulness of T2-weighted fluid-attenuated inversion recovery MR imaging of the CNS. AJR Am J Roentgenol 1999;172:529–36

   PubMedWeb of Science
2. ↵
   Noguchi K, Oqawa T, Inugami A, et al. Acute subarachnoid hemorrhage: diagnosis with fluid-attenuated inversion-recovery MR imaging. Radiology 1995;196:773–77

   PubMedWeb of Science
3. ↵
   Singer MB, Atlas SW, Drayer BP. Subarachnoid space disease: diagnosis with fluid–attenuated inversion-recovery MR imaging and comparisons with gadolinium-enhanced spin-echo MR imaging: blinded reader study. Radiology 1998;208:417–22

   PubMedWeb of Science
4. Kamran S, Bener AB, Alper D, et al. Role of fluid–attenuated inversion-recovery in the diagnosis of meningitis: comparison with contrast-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2004;28:68–72

   CrossRefPubMed
5. ↵
   Mathews VP, Caldemeyer KS, Lowe MJ, et al. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 2000;215:922–24

   PubMed
6. ↵
   Dechambre SD, Duprez T, Grandin CB, et al. High signal in cerebrospinal fluid mimicking subarachnoid haemorrhage on FLAIR following acute stroke and intravenous contrast medium. Neuroradiology 2000;42:608–11

   CrossRefPubMed
7. Rumpel H, Chan LL. Serial FLAIR imaging after Gd-DTPA contrast: pitfalls in stroke trial magnetic resonance imaging. Stroke 2003;34:797–98

   Abstract/FREE Full Text
8. ↵
   Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004;35 (11 suppl 1):2659–61. Epub 2004 Oct 7

   Abstract/FREE Full Text
9. ↵
   Tsuchiya K, Katase S, Yoshino A, et al. FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis. AJR Am J Roentgenol 2001;176:1585–98

   PubMed
10. ↵
    Singh SK, Leeds NE, Ginsberg LE. MR imaging of leptomeningeal metastases: comparison of three sequences. AJNR Am J Neuroradiol 2002;23:817–21

    Abstract/FREE Full Text
11. ↵
    Kanamalla US, Baker KB, Boyko OB. Gadolinium diffusion into subdural space: visualization with FLAIR MR imaging. AJR Am J Roentgenol 2001;176:1604–05

    PubMed
12. ↵
    Kubota T, Yamada K, Kizu O, et al. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors. J Magn Reson Imaging 2005;21:694–700

    CrossRefPubMed
13. ↵
    Bozzao A, Bastianello S, Bozzao L. Superior sagittal sinus thrombosis with high-signal-intensity CSF mimicking subarachnoid hemorrhage on MR FLAIR images. AJR Am J Roentgenol 1997;169:1183–84

    PubMed
14. ↵
    Villalobos-Chavez F, Rodriguez-Uranga JJ, Sanz-Fernandez G. Sequential changes in magnetic resonance in a limbic status epilepticus. Rev Neurol 2005;40:354–57

    PubMed
15. ↵
    Frigon C, Jardine DS, Weinberger E, et al. Fraction of inspired oxygen in relation to cerebrospinal fluid hyperintensity on FLAIR MR imaging of the brain in children and young adults undergoing anesthesia. AJR Am J Roentgenol 2002;179:791–96

    PubMed
16. ↵
    Kim EY, Kim SS, Na DG, et al. Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation. J Comput Assist Tomogr 2005;29:264–69

    CrossRefPubMed
17. ↵
    Lev MH, Schaefer PW. Subarachnoid gadolinium enhancement mimicking subarachnoid hemorrhage on FLAIR MR images: fluid-attenuated inversion recovery. AJR Am J Roentgenol 1999;173:1414–15

    PubMed
18. ↵
    Kanamalla US, Boyko OB. Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease. AJR Am J Roentgenol 2002;179:1350–52

    PubMed
19. ↵
    Maramattom BV, Manno EM, Wijdicks EF, et al. Gadolinium encephalopathy in a patient with renal failure. Neurology 2005;64:1276–78

    Abstract/FREE Full Text
20. ↵
    Mamourian AC, Hoopes PJ, Lewis LD, et al. Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. AJNR Am J Neuroradiol 2000;21:105–11

    Abstract/FREE Full Text
21. ↵
    Melhem ER, Jara H, Eustace S. Fluid-attenuated inversion recovery MR imaging: identification of protein concentration thresholds for CSF hyperintensity. AJR Am J Roentgenol 1997;169:859–62

    CrossRefPubMedWeb of Science
22. ↵
    Bozzao A, Floris R, Fasoli F, et al. Cerebral spinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR MR imaging. Eur Radiol 2003;13:592–97

    PubMedWeb of Science
23. ↵
    Taoka T, Yuh WT, White M, et al. Sulcal hyperintensity on fluid-attenuated inversion recovery MR images in patients without apparent cerebrospinal fluid abnormality. AJR Am J Roentgenol 2001;176:519–24

    PubMedWeb of Science
24. ↵
    Rai A, Hogg JP. Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease. AJNR Am J Neuroradiol 2001;22:1357–61

    Abstract/FREE Full Text
25. ↵
    Wilkinson ID, Griffiths PD, Hoggard N, et al. Unilateral leptomeningeal enhancement after carotid stent detected by magnetic resonance imaging. Stroke 2000;31:848–51

    Abstract/FREE Full Text
26. ↵
    Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 1998;5:491–502

    CrossRefPubMedWeb of Science
27. ↵
    Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999;10:477–84

    CrossRefPubMedWeb of Science
28. ↵
    Arsenault TM, King BF, Marsh JW, et al. Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 1996;71:1150–54

    CrossRefPubMedWeb of Science
29. ↵
    Grobner, T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104–8

    FREE Full Text